MUC5AC and Pancreatic cysts: In this scenario, DNA-based biomarkers, including KRAS and GNAS noted to be elevated in mucin-producing cysts, and supervised machine learning techniques might represent an innovative tool to develop a comprehensive test, CompCyst, based on selected clinical and imaging features combined with cyst fluid genetic and biochemical markers, to guide the management of pancreatic cysts.